HomeCompareGAMCU vs JNJ

GAMCU vs JNJ: Dividend Comparison 2026

GAMCU yields 22.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GAMCU wins by $66.4K in total portfolio value
10 years
GAMCU
GAMCU
● Live price
22.78%
Share price
$8.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$86.5K
Annual income
$8,973.30
Full GAMCU calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GAMCU vs JNJ

📍 GAMCU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGAMCUJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GAMCU + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GAMCU pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAMCU
Annual income on $10K today (after 15% tax)
$1,936.22/yr
After 10yr DRIP, annual income (after tax)
$7,627.30/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, GAMCU beats the other by $6,923.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAMCU + JNJ for your $10,000?

GAMCU: 50%JNJ: 50%
100% JNJ50/50100% GAMCU
Portfolio after 10yr
$53.2K
Annual income
$4,900.54/yr
Blended yield
9.20%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GAMCU
No analyst data
Altman Z
-67.9
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAMCU buys
0
JNJ buys
0
No recent congressional trades found for GAMCU or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGAMCUJNJ
Forward yield22.78%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$86.5K$20.0K
Annual income after 10y$8,973.30$827.78
Total dividends collected$52.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GAMCU vs JNJ ($10,000, DRIP)

YearGAMCU PortfolioGAMCU Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,978$2,277.90$10,676$355.77+$2.3KGAMCU
2$16,649$2,762.84$11,407$389.39+$5.2KGAMCU
3$21,127$3,312.54$12,198$426.53+$8.9KGAMCU
4$26,535$3,928.49$13,056$467.62+$13.5KGAMCU
5$33,003$4,611.19$13,987$513.12+$19.0KGAMCU
6$40,674$5,360.09$14,998$563.56+$25.7KGAMCU
7$49,694$6,173.68$16,098$619.52+$33.6KGAMCU
8$60,222$7,049.46$17,295$681.69+$42.9KGAMCU
9$72,422$7,984.05$18,599$750.82+$53.8KGAMCU
10$86,465$8,973.30$20,022$827.78+$66.4KGAMCU

GAMCU vs JNJ: Complete Analysis 2026

GAMCUStock

Golden Arrow Merger Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related infrastructure industries in the United States and other developed countries. Golden Arrow Merger Corp. was incorporated in 2020 and is based in New York, New York.

Full GAMCU Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GAMCU vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAMCU vs SCHDGAMCU vs JEPIGAMCU vs OGAMCU vs KOGAMCU vs MAINGAMCU vs ABBVGAMCU vs MRKGAMCU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.